Phagocytic activity is impaired in type 2 diabetes mellitus and increases after metabolic improvement

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Lecube, Albert ^a   Pachón, Gisela ^a,b   Petriz, Jordi ^b   Hernández, Cristina ^a   Simó, Rafael ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MALE; METABOLIC ACTIVATION; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; CASE CONTROL STUDY; CLINICAL TRIAL; HOSPITAL DISCHARGE; INTERVENTION STUDY; METABOLISM; MIDDLE AGED; PATHOLOGY;

CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FLOW CYTOMETRY; HUMANS; INTERVENTION STUDIES; MALE; MIDDLE AGED; PATIENT DISCHARGE; PHAGOCYTOSIS;

EID: 80051842679     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023366     Document Type: Article

References (27)

1. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW, (1999) Infections in patients with diabetes mellitus. N Engl J Med 341: 1906-1912.
2. Shah BR, Hux JE, (2003) Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 26: 510-513.
3. Fisher TK, Wolcott R, Wolk DM, Bharara M, Kimbriel HR, et al. (2010) Diabetic foot infections: Aneed for innovative assessments. Int J Low Extrem Wounds 9: 31-36.
4. Yende S, van der Poll T, Lee M, Huang DT, Newman AB, et al. (2010) The influence of pre-existing diabetes mellitus on the host immune response and outcome of pneumonia: analysis of two multicentre cohort studies. Thorax 65: 870-877.
5. Allard R, Leclerc P, Tremblay C, Tannenbaum TN, (2010) Diabetes and the severity of pandemic influenz A (H1N1) infection. Diabetes Care 33: 1491-1493.
6. Ata A, Lee J, Bestle SL, Desemone J, Stain SC, (2010) Postoperative hyperglycemia and surgical site infection in general surgery patients. Arch Surg 145: 858-864.
7. Pozzilli P, Leslie RD, (1994) Infections and diabetes: mechanisms and prospects for prevention. Diabet Med 11: 935-941.
8. Geerlings SE, Hoepelman AI, (1999) Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 26: 259-265.
9. Fornas O, Garcia J, Petriz J, (2000) Flow cytometry counting of CD34+ cells in whole blood. Nat Med 6: 833-836.
10. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, et al. (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370: 1453-1457.
11. Markhoffer W, Stein M, Maeser E, Federlin K, (1992) Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care 15: 256-260.
12. Alexiewicz JM, Kumar D, Smogorewski M, Klin M, Massry SG, (1995) Polymorphonuclear leukocytes in non-insulin-dpendent diabetes mellitus: abnormalities in metabolism and function. Ann Intern Med 123: 919-924.
13. Inoue S, Lan Y, Muran J, Tsuji M, (1996) Reduced hydrogen peroxide production in neutrophils from patients with diabetes. Diabetes Res Clin Pract 33: 119-127.
14. Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, et al. (1997) Impaired leucocyte functions in diabetic patients. Diabet Med 14: 29-34.
15. McManus LM, Blood RC, Prihoda TJ, Blodgett JL, Pinckard RN, (2001) Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia. J Leukoc Biol 70: 395-404.
16. Komura T, Sakai Y, Honda M, Takamura T, Matsushima K, et al. (2010) CD14+ monocytes are vulnerable and functionally impaired Ander endoplasmic reticulum stress in patients with type 2 diabetes. Diabetes 59: 634-643.
17. Geisler C, Almdal T, Bennedsen J, Rhodes JF, Klendorf K, (1982) Monocyte functions in diabetes mellitus. Acta Pathol Microbiol Immunol Scand C 90: 33-37.
18. Wierusz-Wysocka H, Wysocki H, Siekierka H, Wykretowicz A, Szczepanik A, et al. (1987) Evidence of polymorphonuclear neutrophil activation in patients with insulin-dependent diabetes mellitus. J Leuk Biol 42: 519-523.
19. Descamps-Latscha B, Nguyen AT, Feutren G, (1990) Phagocyte oxidative metabolism in cyclosporine- or placebo-treated patients with insulin-dependent (type 1) diabetes mellitus of recent onset. J Autoimmun 3: 201-213.
20. Andrews T, Sullivan KE, (2003) Infections in patients with inherited defects in phagocytic function. Clin Microbiol Rev 16: 597-621.
21. Tebbs SE, Gonzalez AM, Wilson RM, (1991) The role of aldose reductase inhibition in diabetic neutrophil phagocytosis and killing. Clin Exp Immunol 84: 482-487.
22. Patti ME, Corvera S, (2010) The role of mitochondria in the pathogenesis of type 2 diabetes. Endocr Rev 31: 364-395.
23. Falagas ME, Kompoti M, (2006) Obesity and infection. Lancet Infect Dis 6: 438-446.
24. Tanaka S-I, Isoda F, Ishihara Y, Kimura M, Yamakawa T, (2001) T lymphopaenia in relation to body mass index and TNF-alpha in human obesity: adequate weight reduction can be corrective. Clin Endocrinol 54: 347-354.
25. O'Rourke R, Kay T, Scholz M, Diggs B, Jobe B, et al. (2005) Alterations in T-cell subset frequency in peripheral blood in obesity. Obes Surg 15: 1463-1468.
26. Tong Q, Dalgin G, Xu H, Ting CN, Leiden JM, et al. (2000) Function of GATA transcription factors in preadipocyte-adipocyte transition. Science 290: 134-138.
27. Menghini R, Marchetti V, Cardellini M, Hribal ML, Mauriello A, et al. (2005) Phosphorylation of GATA2 by Akt increases adipose tissue differentiation and reduces adipose tissue-related inflammation: a novel pathway linking obesity to aterosclerosis. Circulation 111: 1946-1953.